Use of CA-125 and ultrasound in high-risk women

International Journal of Gynecological Cancer

Volumn 12, Issue 1, 2002, Pages 86-91

  Laframboise, S ^a   Nedelcu, R ^a   Murphy, J ^a   Cole, D E C ^b   Rosen, B ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRCA genes; CA 125; Familial ovarian cancer; Prophylactic surgery; Ultrasound

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; ULTRASOUND;

ADULT; AGED; BRCA1 PROTEIN; CA-125 ANTIGEN; CARCINOMA, ENDOMETRIOID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036195547     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01055.x     Document Type: Article

References (27)

1. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
2. Breast and ovarian cancer incidence in BRCA1 mutation
3. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families
4. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
5. Detection of malignant ovarian neoplasms: A review of the literature: I. Detection of the patient at risk; clinical, radiological and cytological detection
6. Screening for ovarian cancer: The preliminary experience of a familial ovarian cancer center
7. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer
8. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography
9. Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration; a prospective cohort study
10. Ultrasound screening for familial ovarian cancer
11. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation
12. Ovarian cancer: Screening, treatment, follow-up
13. Rapid detection of BRCA1 mutations by the protein truncation test
14. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer
15. Screening of ovarian cancer: A pilot randomized controlled trial
16. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer
17. Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma
18. The CA 125 tumor associated antigen: A review of the literature
19. Ovarian cancer risk reduction after bilateral prophylactic oophorectomy (BPO) in BRCA1 and BRCA2 mutation carriers
20. Risks of cancer in BRCAl-mutation carriers
21. Characteristics relating to ovarian cancer risk collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women
22. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer. III. Oral contraceptive use
23. Oral contraceptives and the risk of hereditary ovarian cancer
24. Infertility and risk of fatal ovarian cancer in a prospective cohort of US women
25. Infertility, fertility drugs, and invasive ovarian cancer: A case-control study
26. Cancer risks in BRCA2 mutation carriers